Daily Sepsis Research Analysis
Three impactful sepsis studies advance both clinical decision-making and risk stratification. A multicenter cohort proposes osmolarity-defined dehydration to individualize initial fluid resuscitation, while two large database analyses introduce practical prognostic tools: serum glucose/potassium ratio and longitudinal RDW trajectories, including in SA-AKI.
Summary
Three impactful sepsis studies advance both clinical decision-making and risk stratification. A multicenter cohort proposes osmolarity-defined dehydration to individualize initial fluid resuscitation, while two large database analyses introduce practical prognostic tools: serum glucose/potassium ratio and longitudinal RDW trajectories, including in SA-AKI.
Research Themes
- Individualized fluid resuscitation guided by hyperosmolar dehydration
- Simple metabolic ratios (glucose/potassium) for prognostication
- Dynamic hematologic biomarkers (RDW trajectories) in SA-AKI
Selected Articles
1. Hyperosmolar Dehydration in Sepsis: Implications for Initial Fluid Management.
In a 20-center, nationwide cohort (n=4,487) with 1:1 propensity matching (1,537 pairs), hyperosmolar dehydration (serum osmolarity ≥295 mOsm/L) was common (58.1%) and associated with higher 30-day mortality (aOR 1.18, 95% CI 1.00–1.39). Liberal pre-ICU fluids (>30 mL/kg) improved lactate without worsening SOFA among dehydrated patients, but in non-dehydrated patients increased SOFA and mechanical ventilation risk without lactate benefit.
Impact: This multicenter study operationalizes a simple dehydration marker (serum osmolarity) to personalize initial fluid resuscitation in sepsis, challenging one-size-fits-all bolus strategies.
Clinical Implications: Check serum osmolarity at sepsis diagnosis. Consider liberal fluids (>30 mL/kg) for hyperosmolar dehydration to improve perfusion (lactate) without organ burden, but avoid liberal boluses in non-dehydrated patients due to increased organ dysfunction and ventilation risk.
Key Findings
- Hyperosmolar dehydration prevalence was 58.1% among 4,487 ICU sepsis patients.
- 30-day mortality was higher with hyperosmolar dehydration (adjusted OR 1.18, 95% CI 1.00–1.39).
- Liberal pre-ICU fluids (>30 mL/kg) improved lactate in dehydrated patients (p=0.009) without increasing SOFA (p=0.111).
- In non-dehydrated patients, liberal fluids increased SOFA (p=0.034) and mechanical ventilation risk (p<0.001) without improving lactate (p=0.388).
Methodological Strengths
- Nationwide multicenter cohort with 1:1 propensity score matching and multivariable adjustment.
- Use of restricted cubic splines to model fluid volume as a continuous exposure.
Limitations
- Observational design with potential residual confounding and selection bias despite matching.
- Hyperosmolar dehydration defined by a serum osmolarity threshold may misclassify mixed states; external validation needed.
Future Directions: Prospective trials testing osmolarity-guided fluid resuscitation strategies and refining thresholds for dehydration phenotypes.
OBJECTIVE: Patients with sepsis are prone to hypovolemia which can lead to hyperosmolar dehydration and result in intracellular volume depletion. This study aimed to assess the effect of hyperosmolar dehydration on the clinical outcomes of patients with sepsis and its potential as an indicator of optimal initial fluid management. DESIGN: A nationwide propensity score-matched cohort study analyzing data prospectively collected between September 2019 and December 2021. SETTING: Twenty tertiary- or univer
2. Associations of serum glucose/potassium ratio with short-term and long-term mortality in sepsis patients: a retrospective cohort study based on the MIMIC-IV database.
In 31,717 sepsis patients, the serum glucose/potassium ratio (GPR) showed a U-shaped association with mortality across 30-day, 90-day, 180-day, and 1-year outcomes. Mortality risk rose dose-dependently with higher GPR (highest in Q4 ≥2.169), and an optimal 30-day cutoff was 1.49. Results were robust in extensive sensitivity and subgroup analyses.
Impact: GPR uses universally available labs to provide immediate, scalable risk stratification in sepsis, demonstrating consistent prediction across multiple horizons and robustness to key comorbidities.
Clinical Implications: Incorporate GPR into early triage and monitoring. Avoid extremes by correcting hyperglycemia and dyskalemias promptly; consider flagging GPR >2.17 or near the U-shaped nadir deviations (around 1.49) in clinical decision support.
Key Findings
- Among 31,717 sepsis patients, higher GPR quartiles had progressively higher mortality; Q4 (≥2.169) had the greatest risk.
- Restricted cubic splines revealed a U-shaped relationship; the optimal 30-day mortality cutoff was approximately 1.49.
- Associations persisted after excluding diabetes, acute renal failure, and chronic liver disease, and across multiple follow-up horizons.
Methodological Strengths
- Very large sample size with multivariable Cox models and restricted cubic spline analysis.
- Extensive sensitivity analyses, including subgroup exclusions, supported robustness.
Limitations
- Single-database, retrospective design limits causal inference and generalizability.
- GPR may be influenced by therapies (insulin, fluids, potassium replacement); external validation and dynamic modeling at bedside are needed.
Future Directions: Prospective validation and interventional studies to test whether managing glucose and potassium to maintain GPR near optimal ranges improves outcomes.
This study evaluated the prognostic value of glucose/potassium ratio (GPR) in sepsis using MIMIC-IV data (n = 31,717). Patients were stratified by GPR quartiles (Q1: <1.450 to Q4: ≥2.169). Adjusted Cox models demonstrated a dose-dependent increase in mortality in patients with higher GPR levels (P < 0.001), with the highest risk of mortality observed in Q4. Restricted cubic spline analysis revealed a U-shaped relationship between GPR and mortality (30-day optimal cutoff: 1.49). Sensitivity anal
3. Longitudinal modeling of red blood cell distribution width dynamics and mortality risk in critically Ill patients with sepsis-associated acute kidney injury.
Among 6,694 SA-AKI patients, four RDW trajectories were identified. The Rapid Increase group (6.1%) had the highest disease severity, worst labs, and markedly elevated 28-day mortality risk versus Stable Low after full adjustment (HR 4.27, P<0.001), with consistent patterns for 90-day outcomes and resource use. Findings persisted after adjusting for transfusion/hemorrhage and excluding transfused patients.
Impact: Introduces dynamic RDW trajectories as robust prognostic signatures in SA-AKI, supporting serial hematologic monitoring and risk-adaptive care pathways beyond static thresholds.
Clinical Implications: Serial RDW tracking can identify a high-risk Rapid Increase phenotype in SA-AKI, prompting intensified monitoring, earlier renal-protective strategies, and proactive resource planning (e.g., CRRT).
Key Findings
- GBTM identified four RDW trajectories: Stable Low (27.8%), Gradual Increase (38.5%), Continuous Increase (27.6%), and Rapid Increase (6.1%).
- Rapid Increase group had the highest 28-day mortality risk vs Stable Low after full adjustment (HR 4.27, P<0.001) and similar patterns for 90-day outcomes and resource use.
- Associations were robust across subgroup, multiple-imputation, relaxed-inclusion cohorts, and after adjusting for transfusion/hemorrhage or excluding transfused patients.
Methodological Strengths
- Use of Group-Based Trajectory Modeling to capture longitudinal biomarker dynamics.
- Comprehensive sensitivity analyses including adjustment for transfusion/hemorrhage and exclusion analyses.
Limitations
- Retrospective single-database analysis limits causal inference.
- RDW is a nonspecific marker influenced by multiple conditions; clinical utility requires prospective validation and integration with other variables.
Future Directions: Prospective implementation studies of RDW trajectory monitoring and testing whether trajectory-guided clinical pathways improve SA-AKI outcomes.
BACKGROUND: Sepsis-associated acute kidney injury (SA-AKI) is a critical condition with high mortality. Red cell distribution width (RDW) has emerged as a potential dynamic biomarker, but longitudinal RDW changes in SA-AKI remain underexplored. METHODS: This retrospective cohort study analyzed adult SA-AKI patients from the MIMIC-IV database (2008-2022). Group-Based Trajectory Modeling (GBTM) identified distinct longitudinal RDW patterns. Primary outcome was 28-day all-cause mortality. Secondary ou